tiprankstipranks
Seres Therapeutics (MCRB)
NASDAQ:MCRB
US Market

Seres Therapeutics (MCRB) Income Statement

Compare
1,053 Followers

Seres Therapeutics Income Statement

Last quarter (Q3 2024), Seres Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Seres Therapeutics's net income was $88.78M. See Seres Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 126.33M$ 7.13M$ 144.93M$ 33.22M
Gross Profit
$ 0.00$ 125.62M$ 6.12M$ 143.19M$ -57.35M
Operating Expenses
$ 121.31M$ 233.60M$ 253.62M$ 209.42M$ 121.34M
Depreciation and Amortization
$ 0.00$ 6.24M$ 11.85M$ 9.22M$ 8.89M
EBITDA
$ -121.31M$ -94.31M$ -237.51M$ -56.72M$ -77.31M
Operating Income
$ -121.31M$ -107.98M$ -246.49M$ -64.49M$ -88.13M
Other Income/Expenses
$ 121.45M$ -5.74M$ -3.67M$ -1.08M$ -997.00K
Pretax Income
$ 136.00K$ -113.72M$ -250.16M$ -65.58M$ -89.13M
Net Income
$ 136.00K$ -113.72M$ -253.82M$ -61.50M$ -86.45M
Per Share Metrics
Basic EPS
$ 0.00$ -0.89$ -2.35$ -0.67$ -1.08
Diluted EPS
$ 0.00$ -0.89$ -2.35$ -0.67$ -1.08
Weighted Average Shares Outstanding
155.40M 128.00M 108.08M 91.70M 79.79M
Weighted Average Shares Outstanding (Diluted)
155.40M 128.00M 108.08M 91.70M 79.79M
Currency in USD

Seres Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis